The Senior care pharmacistHumansParkinson DiseaseLevodopaCarbidopaAntiparkinson Agents
Dopamine Dysregulation Syndrome in Parkinson's Disease.
Audrey J Lee, Linda H Poon
Published: 202510.4140/TCP.n.2025.450
Abstract
This case study examines how patients with Parkinson's disease (PD) may develop dopamine dysregulation syndrome (DDS), a condition characterized by the misuse of dopamine replacement therapy through excessive self-directed dosing beyond what is neces…
Preview only. Read the full abstract at the source